BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...

Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...

GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

The people below may be eligible to receive tirzepatide (Mounjaro) on the NHS. This is to ensure patients at greatest risk ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line ...

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

In a Cleveland Clinic cohort, patients who stopped treatment for obesity had smaller weight losses to start, making these ...

Shares of Scholar Rock Holdings jumped Wednesday after the biopharmaceutical firm reported positive results from a ...